Resiquimod is an imidazoquinoline. A substance being studied in the treatment of some types of skin cancer. When put on the skin, resiquimod causes some immune cells to make certain chemicals that may help them kill tumor cells. It is also being studied to find out if adding it to a tumor vaccine improves the antitumor immune response. It is a kind of imidazoquinoline and a type of immunomodulator. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include resiquimodum, alpha-dimethyl-1H-imidazo(4, 5-c)quinoline-1-ethanol and R-848. Its PubChem CID is 159603.
Resiquimod
| CAS No | 144875-48-9 |
|---|---|
| Molecular Formula | C17H22N4O2 |
| Molecular Weight | 314.4 g/mol |
| Synonyms | 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Resiquimod is an imidazoquinoline. A substance being studied in the treatment of some types of skin cancer. When put on the skin, resiquimod causes some immune cells to make certain chemicals that may help them kill tumor cells.
The listed CAS number is 144875-48-9.
The listed molecular formula is C17H22N4O2.
The listed molecular weight is 314.4 g/mol.
1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol.
The source lists resiquimodum, alpha-dimethyl-1H-imidazo(4, 5-c)quinoline-1-ethanol and R-848.